Ir o contido principal

Publicacións

2026

LEAP2 acts in hepatocytes and at central level, alleviates steatosis and inflammation but resistance in obese and aging

Miguéns MV, Quintela-Vilariño C, Casado S, de Oliveira-Diz T, Müller TD, Nogueiras R, Diéguez C, Tovar S
Life Sci. 2026 Mar 1;388:124219
Diabesity, Functional Obesomics , Molecular Metabolism

2025

Ceramides in the central control of metabolism

López M, Diéguez C, Tena-Sempere M & González-García I.
Trends in Endocrinology and Metabolism (2025) 36:11-14
Functional Obesomics , NeurObesity, Neuroendocrine Regulation of Metabolism

Concurrent L1 retrotransposition events promote reciprocal translocations in human tumorigenesis

Zumalave S, Santamarina M, P Espasandín N, Zamora J, Garcia-Souto D, Temes J, Baker TM, Rodríguez-Castro J, Otero P, Pequeño-Valtierra A, Otero I, Oitabén A, Álvarez EG, Díaz-Arias I, Martínez-Fernández M, Blanco MG, Van Loo P, Cristofari G, Rodriguez-Martin B, Tubio JMC
Science. 2026 Feb 26:eaee4513
Mobile Genomes

Epidemiological and clinical data from the European Lipodystrophy Registry

Ceccarini G, Vatier C, Akinci B, Belalem I, Broekema M, Csajbok E, Rosaria D'Apice M, Gambineri A, Heldt K, Heni M, Kleinendorst L, Krause K, Lattanzi G, Miehle K, Palladino L, Prodam F, Santini F, Santos Silva E, Savage DB, Sbraccia P, Scherer T, Sorkina E, Štotl I, Vantyghem MC, Vigouroux C, Vorona E, Araújo-Vilar D, Wabitsch M, Nagel G, von Schnurbein J; ECLip Registry Consortium
Eur J Endocrinol. 2025 Oct 30;193(5):685-703
Thyroid and Metabolic Diseases Unit

Fasudil inhibits α-synuclein aggregation through ROCK-inhibition-mediated mechanisms. Neurotherapeutics.

Lage L, Rodriguez-Perez AI, Labandeira-Garcia JL, Dominguez-Meijide A
Neurotherapeutics. 2025 Mar;22(2):e00544
Cell and Molecular Neurobiology of Parkinson's Disease